Enliven Therapeutics Inc

ELVNNASDAQ
$57.86
-2.64-4.36%
At close: Aug 28, 5:00 PM EST
$57.69
-0.17-0.29%
After Hours: Aug 28, 4:05 PM EST

Enliven Therapeutics Ownership & Insider Activity

Enliven Therapeutics (ELVN) institutional and insider ownership, recent insider transactions and ownership breakdown.

Insiders own 0.6% of shares outstanding. Institutional investors hold 51.5%. Over the past 90 days, insiders made 6 sales worth $53.2M.

Shares Outstanding

71.438M

Shares Float

49.020M

Insider Shares Owned

385.074K

Insider % Owned

0.6%

Institutional Shares Held

37.765M

Institutional % Held

51.5%

Ownership Breakdown

Net Insider Activity by Month

Purchases (90d)

0

Sales (90d)

6

$53.2M total

Net Activity

Net Selling

Net Value (90d)

-$53.2M

Enliven Therapeutics Insider Transactions (Last 6 Months)

See all insider trades
DateInsiderTitleTypeSharesPriceValue
Aug 17, 2026Benjamin HohlCHIEF FINANCIAL OFFICERSELL6.018K$58.58$353K
Aug 17, 2026Louise Helen CollinsCHIEF MEDICAL OFFICERSELL-OPTIONS$30.53$281K